GLP-3 RT 50mg Peptides
Built for disciplined research, this vial delivers the consistency laboratories depend on.
Primavora GLP-3 RT is a lyophilized research peptide supplied in a sealed vial format for controlled handling and precise formulation. This unflavored, unadulterated peptide is provided as a dry powder to support stability during storage and transport. Total content: 50mg.
- Each vial contains 50mg of GLP-3 RT, a research-grade peptide prepared to support assay development, method standardization, and exploratory analysis where consistent composition and reliable performance are essential.
Designed for laboratory workflows, the lyophilized form allows researchers to reconstitute under their preferred conditions and aliquot as needed for in vitro, ex vivo, or analytical applications. The material is presented for clarity and ease of tracking in research environments, with straightforward labeling and a clean composition free from flavors, fillers, or unnecessary additives.
Consistency is central to reproducible results. Each batch is produced under controlled conditions with documented lot traceability and is evaluated to confirm identity and purity before release. Researchers can expect a uniform appearance upon reconstitution, predictable behavior across runs, and dependable composition that supports protocol repeatability. The 50mg presentation offers flexibility for method development, pilot assays, and scale-up studies where precise measurement and careful handling matter.
Primavora operates with rigorous standards that prioritize quality, transparency, and compliance. Our peptides are sourced and packaged in the USA, handled with attention to cleanliness, and batch-tested to validate specifications. Certificates of Analysis are available for qualified laboratories to support internal documentation and quality systems.
Research Use Only: This material is furnished exclusively for qualified laboratory research. Not for human consumption, injection, or clinical use. Not for veterinary use. Handle using appropriate laboratory practices and dispose of all materials in accordance with institutional and regulatory requirements.
Choose Primavora for a dependable GLP-3 RT resource—precision-made, carefully verified, and supported by a brand built around scientific standards.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
